市場調查報告書
商品編碼
1307000
全球生物晶片市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測Global Biochips Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
預計到2030年,全球生物晶片市場需求將從2022年的89.1億美元成長至271.9億美元,2023-2030年復合年成長率為14.97%。
生物晶片,也稱為微陣列,是由微小晶片或玻璃載玻片組成的小型設備,用於研究DNA、RNA和蛋白質等生物分子。這些裝置有數千至數百萬個微觀點,每個點含有不同的生物分子。它們的工作原理是將感興趣的生物分子與晶片表面的光點結合,然後使用螢光、化學發光或質譜等各種方法對其進行分析。通過分析晶片上每個點的訊號,研究人員可以獲得被分析生物樣品的大量資訊。
個性化醫療是指根據個人的基因構成量身定做醫療方案,這一日益成長的趨勢推動了對生物晶片的需求。生物晶片用於分析DNA、RNA和蛋白質樣本,可為製定個性化治療方案提供有價值的資訊。基因組學和蛋白質組學研究的進展,如下一代測序和質譜技術的發展,也增加了該市場的需求曲線。這些技術用於快速有效地分析大量生物數據。微陣列技術在研究、診斷和藥物開發領域的應用正在迅速增加。生物晶片是微陣列技術的關鍵組成部分,用於研究基因表達和蛋白質相互作用。包括癌症、心血管疾病和糖尿病在內的慢性疾病發病率的上升也支持了這一市場。生物晶片用於診斷、治療和監測這些疾病,由於人口老齡化和不健康的生活方式等因素,這些疾病正變得越來越普遍。晶片實驗室和微流控技術的發展等技術進步也有助於該市場的成長。這些技術能夠更快、更準確地分析生物樣本,對研究和診斷至關重要。各國政府的大量投資也支持了這一市場。例如,美國政府發起了多項旨在推動基因組學研究和個性化醫療的計劃,預計這將促進市場需求。
研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於在全球範圍內清晰地了解行業結構並評估競爭吸引力。此外,這些工具還對全球生物晶片市場的各個細分市場進行了全面評估。生物晶片行業的成長和趨勢為本研究提供了整體方法。
生物晶片市場報告的這一部分提供了國家和地區層面細分市場的詳細數據,從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區生物晶片市場的當前和未來需求。此外,報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。生物晶片市場的主要參與者包括雅培實驗室、安捷倫科技公司、珀金埃爾默公司、Fluidigm公司、Illumina公司、通用電氣醫療保健公司、Bio-Rad實驗室公司、賽默飛世爾科技公司、LI-COR公司、分子設備有限責任公司。本節包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
The global demand for Biochips Market is presumed to reach the market size of nearly USD 27.19 BN by 2030 from USD 8.91 BN in 2022 with a CAGR of 14.97% under the study period 2023 - 2030.
Biochips, also known as microarrays, are small devices made up of tiny microchips or glass slides that are used to study biological molecules such as DNA, RNA, and proteins. These devices have thousands to millions of microscopic spots, each containing a different biological molecule. These work by binding the biological molecules of interest to the spots on the chip's surface, which can then be analyzed using various methods, such as fluorescence, chemiluminescence, or mass spectrometry. By analyzing the signals from each spot on the chip, researchers can obtain a wealth of information about the biological samples being analyzed.
The growing trend towards personalized medicine, which involves tailoring medical treatment to an individual's genetic makeup, is driving the demand for biochips. These are used to analyze DNA, RNA, and protein samples, which can provide valuable information for developing personalized treatment plans. Advancements in genomics and proteomics research, such as the development of next-generation sequencing and mass spectrometry technologies, are also adding to the demand curve of this market. These are used in technologies to analyze large amounts of biological data quickly and efficiently. The adoption of microarray technology is increasing rapidly in research, diagnostics, and drug development. Biochips are a key component of microarray technology, which is used to study gene expression and protein interactions. The increasing incidence of chronic diseases, including cancer, cardiovascular diseases, and diabetes, is also supporting this market. Biochips are used in the diagnosis, treatment, and monitoring of these diseases, which are becoming more prevalent due to factors such as ageing populations and unhealthy lifestyles. Technological advancements, such as the development of lab-on-a-chip and microfluidics technologies, are also assisting the growth of this market. These technologies allow for faster and more accurate analysis of biological samples, which is critical in research and diagnostics. Heavy investments from various Governments are also supporting this market. For example, the US government has launched several initiatives aimed at advancing genomics research and personalized medicine, which is expected to boost the demand.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biochips. The growth and trends of biochips industry provide a holistic approach to this study.
This section of the biochips market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Biochips market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biochips market include Abbott Laboratories, Agilent Technologies, Inc., PerkinElmer, Inc., Fluidigm Corp., Illumina, Inc., GE Healthcare, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., LI-COR, Inc., Molecular Devices, LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.